Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin).
about
Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.A systematic review and meta-analysis on the effect of angiogenesis blockade for the treatment of gastric cancer
P2860
Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Value of FGFR2 expression for ...... capecitabine and oxaliplatin).
@en
Value of FGFR2 expression for ...... eceiving pazopanib plus CapeOX
@nl
type
label
Value of FGFR2 expression for ...... capecitabine and oxaliplatin).
@en
Value of FGFR2 expression for ...... eceiving pazopanib plus CapeOX
@nl
prefLabel
Value of FGFR2 expression for ...... capecitabine and oxaliplatin).
@en
Value of FGFR2 expression for ...... eceiving pazopanib plus CapeOX
@nl
P2093
P2860
P1476
Value of FGFR2 expression for ...... capecitabine and oxaliplatin).
@en
P2093
Ho Yeong Lim
Jeeyun Lee
Joon Oh Park
Kyoung-Mee Kim
Se Hoon Park
Seung Tae Kim
Soomin Ahn
Su Jin Lee
Won Ki Kang
Young Suk Park
P2860
P2888
P304
P356
10.1007/S00432-016-2143-2
P577
2016-03-16T00:00:00Z